Results 21 to 30 of about 184,937 (258)

Myelin oligodendrocyte glycoprotein antibody-associated disease presenting as isolated simultaneous bilateral optic neuritis in a child [PDF]

Oman Journal of Ophthalmology
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is the most recently defined distinct demyelinating disorder of the central nervous system which has heterogeneous clinical manifestations.
Gurcharan Singh, Ziaur Rahman
doaj   +2 more sources

Case Report: Fundus findings in myelin oligodendrocyte glycoprotein-associated optic neuritis [PDF]

Frontiers in Ophthalmology
Myelin oligodendrocyte glycoprotein-associated optic neuritis (MOG-ON) is a sight-threatening demyelinating disorder that can present with various ocular manifestations.
John R. Wilson, Olivia W. Cummings, Matthew S. Elitt, Gregory P. Van Stavern   +3 more
doaj   +2 more sources

Extensive brainstem lesions in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A case report

Radiology Case Reports
Myelin oligodendrocyte glycoprotein antibody-associated disease is a group of central nervous system demyelinating disorders caused by autoantibodies.
Yasuyuki Kojita, MD, PhD, Nonoka Okada, MD, Mayumi Hirakawa, MD, Kanako Fujii, MD, Takao Satou, MD, PhD, Kazunari Ishii, MD, PhD   +5 more
doaj   +2 more sources

Clinical and Neuroimaging Characteristics of Pediatric Acute Disseminating Encephalomyelitis With and Without Antibodies to Myelin Oligodendrocyte Glycoprotein

Frontiers in Neurology, 2020
Objective: To compare the clinical and neuroimaging characteristics of anti-myelin oligodendrocyte glycoprotein antibody (MOG-ab) negative and positive pediatric acute disseminating encephalomyelitis (ADEM) patients.Methods: Clinical characteristics ...
Shuizhen Zhou, Lifei Yu, Linmei Zhang
exaly   +3 more sources

Myelin basic protein peptide 45–89 induces the release of nitric oxide from microglial cells. [PDF]

, 2002
Continuous (24 h) exposure of mixed oligodendrocyte/microglial cells to peptides 45–89 derived from citrullinated C8 isoforms of myelin basic protein (MBP) induces cell death.
Pichkhadze, B., Machaidze, G., Mikeladze, D., Shanshiashvili, L., Ramsden, Jeremy J.   +4 more
core   +7 more sources

The nomogram model predicts relapse risk in myelin oligodendrocyte glycoprotein antibody-associated disease: a single-center study

Frontiers in Immunology
BackgroundMyelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is an autoimmune disorder of the central nervous system, characterized by seropositive MOG antibodies.
Meini Zhang
exaly   +3 more sources

Myelin Oligodendrocyte Glycoprotein Antibody Disease – MOGAD

Indian Journal of Pediatrics
V. Gowda, G. Kumar, U. Kinhal, Anita Mahadevan   +3 more
semanticscholar   +3 more sources

Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria.

Lancet Neurology, 2023
Serum antibodies directed against myelin oligodendrocyte glycoprotein (MOG) are found in patients with acquired CNS demyelinating syndromes that are distinct from multiple sclerosis and aquaporin-4-seropositive neuromyelitis optica spectrum disorder ...
B. Banwell, J. Bennett, R. Marignier, H. Kim, F. Brilot, E. Flanagan, S. Ramanathan, P. Waters, S. Tenembaum, Jennifer S. Graves, T. Chitnis, A. Brandt, C. Hemingway, R. Neuteboom, L. Pandit, M. Reindl, A. Saiz, D. Sato, K. Rostásy, Friedemann Paul, S. Pittock, K. Fujihara, Jacqueline Palace   +22 more
semanticscholar   +1 more source

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management

Frontiers in Neurology, 2022
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is the most recently defined inflammatory demyelinating disease of the central nervous system (CNS).
Elia Sechi, Laura Cacciaguerra, John Chen, S. Mariotto, G. Fadda, A. Dinoto, A. Lopez-Chiriboga, S. Pittock, E. Flanagan   +8 more
semanticscholar   +1 more source

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges

Journal of Neurology, 2023
New diagnostic criteria for myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) have recently been proposed, distinguishing this syndrome from other inflammatory diseases of the central nervous system.
A. Al-Ani, John Chen, F. Costello
semanticscholar   +1 more source